Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -61.10% is 26% below its 2-year average of -48.53%, around the middle of its 2-year range (-76.43%–-27.68%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.45% below its 12-month average of -49.10%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -61.10%.
RETURN ON INVESTED CAPITAL (ROIC)
-61.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-49.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.45%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.39%
median of 720 covered companies
CURRENT VS SECTOR MEDIAN
-83.01%
vs the sector median at left
BridgeBio Oncology Therapeutics Inc.
Market Cap
$287.88M
Return on Invested Capital (ROIC)
-61.10%
TTM Avg
-49.10%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$288.21M
Return on Invested Capital (ROIC)
-49.76%
TTM Avg
-54.76%
3Y Avg
-73.23%
5Y Avg
-84.98%
Market Cap
$288.33M
Return on Invested Capital (ROIC)
-20.40%
TTM Avg
-43.02%
3Y Avg
-57.92%
5Y Avg
-48.43%
Market Cap
$286.75M
Return on Invested Capital (ROIC)
-14.06%
TTM Avg
-26.07%
3Y Avg
-28.37%
5Y Avg
-26.89%
Market Cap
$285.37M
Return on Invested Capital (ROIC)
-129.90%
TTM Avg
-509.42%
3Y Avg
-303.54%
5Y Avg
-247.13%
Market Cap
$282.68M
Return on Invested Capital (ROIC)
-27.62%
TTM Avg
-16.38%
3Y Avg
-32.77%
5Y Avg
-39.71%
Market Cap
$296.59M
Return on Invested Capital (ROIC)
-136.49%
TTM Avg
-130.82%
3Y Avg
-85.38%
5Y Avg
-76.42%
Market Cap
$278.73M
Return on Invested Capital (ROIC)
-15.69%
TTM Avg
-4.06%
3Y Avg
-9.73%
5Y Avg
-12.88%
Market Cap
$278.40M
Return on Invested Capital (ROIC)
-31.62%
TTM Avg
-73.81%
3Y Avg
-69.44%
5Y Avg
-42.80%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BridgeBio Oncology Therapeutics Inc. (BBOT) | $287.88M | -61.10% | -49.10% | N/A | N/A |
| Abeona Therapeutics Inc. (ABEO)vs › | $288.21M | -49.76% | -54.76% | -73.23% | -84.98% |
| Sagimet Biosciences Inc. (SGMT)vs › | $288.33M | -20.40% | -43.02% | -57.92% | -48.43% |
| Standard BioTools Inc. (LAB)vs › | $286.75M | -14.06% | -26.07% | -28.37% | -26.89% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $285.37M | -129.90% | -509.42% | -303.54% | -247.13% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.68M | -27.62% | -16.38% | -32.77% | -39.71% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $296.59M | -136.49% | -130.82% | -85.38% | -76.42% |
| Aurora Cannabis Inc. (ACB)vs › | $278.73M | -15.69% | -4.06% | -9.73% | -12.88% |
| SAB Biotherapeutics, Inc. (SABS)vs › | $278.40M | -31.62% | -73.81% | -69.44% | -42.80% |
| Fate Therapeutics, Inc. (FATE)vs › | $276.62M | -58.72% | -52.25% | -49.23% | -41.07% |
ROIC
-61.1%
ROE
-56.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -61.10% |
| 2026-03-31 | -45.04% |
| 2025-12-31 | -35.23% |
| 2025-09-30 | -27.68% |
| 2025-06-30 | -76.43% |
| 2025-03-31 | -70.40% |
| 2024-12-31 | -41.63% |
| 2024-09-30 | -30.71% |
